Lumibird SA Overview
Pro stress-test →Lumibird designs, manufactures, and sells scientific laser solutions for applications in research, industrial sectors including manufacturing and defense, and medical fields including ophthalmology and dermatology. The company operates two divisions—Photonics and Medical—serving diverse global markets across Europe, North America, and Asia with vertically integrated laser technologies.
Strategic Profile
Pro stress-test →Lumibird was created through the merger of Quantel and Keopsys in October 2017, combining decades of French laser expertise into a vertically integrated photonics group. The company generates a majority of its revenue from scientific and industrial applications. Strategic growth is driven by defense contracts, medical acquisitions, and emerging applications in autonomous systems and LiDAR sensors.
Competitive Landscape
Pro stress-test →Lumibird competes in fragmented laser markets against specialized players (Coherent, IPG Photonics in fiber; Spectranetics in medical; various defense contractors) and diversified conglomerates. Competitive advantages include vertically integrated manufacturing, proprietary solid-state and fiber technology, strong French defense relationships, and emerging leadership in eye-safe LiDAR—but faces pricing pressure in commodity segments and competition from larger diversified peers.
Industry Context
Lumibird SA operates in Photonics & Laser Technology Manufacturing.
Key facts
Founded: 2017 (merger of Quantel 1970 and Keopsys 1997) · Headquarters: Lannion, France · Employees: 1,068 · Revenue: $238M · Market cap: $594M